Heinemann Christian, Schliemann-Willers Sibylle, Oberthür Christine, Hamburger Matthias, Elsner Peter
Department of Dermatology and Dermatological Allergology, University of Jena, Germany.
Planta Med. 2004 May;70(5):385-90. doi: 10.1055/s-2004-818963.
Lipophilic extracts of Isatis tinctoria L. exhibit significant activity against several clinically relevant targets of inflammation. The alkaloid tryptanthrin was identified as one of the active principles in woad and characterised as a potent dual inhibitor of COX-2 and 5-LOX. Here, the anti-inflammatory efficacy of topical application of three different Isatis extracts and tryptanthrin was investigated in human volunteers. Two different models were used, namely the sodium lauryl sulphate (SLS)-induced irritant contact dermatitis (ICD) and UVB-induced erythema. Twenty healthy volunteers without any skin disease participated in the study. Cumulative irritant contact dermatitis was induced on test fields on the volunteers' backs by twice daily application of 0.5 % sodium lauryl sulphate over a period of four days. Half of the test fields were treated with the test substances during the eliciting phase, while the remaining test fields were treated over a period of 4 days after induction of dermatitis. In the second model, a UVB erythema on the volunteers' lower backs was induced using the double minimal erythema dose (MED). Twenty-four hours after irradiation the test fields were treated with the test substances over a period of 3 days. All reactions were assessed visually and by non-invasive bioengineering methods (evaporimetry and chromametry). Treatment with extracts during the ICD eliciting phase led to a significantly smaller increase of visual scores and transepidermal water loss compared to the untreated test field. For tryptanthrin this benefit was also observed, but the improvement was not statistically significant. When treatment was performed after completing the eliciting phase, accelerated resolution of the irritant reaction could not be observed. In the UVB erythema model anti-inflammatory effects of the test substances were not observed.
菘蓝的亲脂性提取物对几种临床相关的炎症靶点具有显著活性。生物碱色胺酮被确定为菘蓝中的活性成分之一,并被表征为COX - 2和5 - LOX的有效双重抑制剂。在此,研究了三种不同菘蓝提取物和色胺酮局部应用于人类志愿者的抗炎效果。使用了两种不同的模型,即十二烷基硫酸钠(SLS)诱导的刺激性接触性皮炎(ICD)和UVB诱导的红斑。20名无任何皮肤疾病的健康志愿者参与了该研究。通过在4天内每天两次在志愿者背部的测试区域涂抹0.5%的十二烷基硫酸钠来诱导累积性刺激性接触性皮炎。在激发阶段,一半的测试区域用受试物质进行处理,而其余测试区域在皮炎诱导后进行为期4天的处理。在第二个模型中,使用双倍最小红斑量(MED)在志愿者下背部诱导UVB红斑。照射24小时后,测试区域用受试物质处理3天。所有反应通过视觉和非侵入性生物工程方法(蒸发测定法和色度测定法)进行评估。与未处理的测试区域相比,在ICD激发阶段用提取物处理导致视觉评分和经表皮水分流失的增加显著更小。对于色胺酮也观察到了这种益处,但改善在统计学上不显著。在完成激发阶段后进行处理时,未观察到刺激性反应的加速消退。在UVB红斑模型中未观察到受试物质的抗炎作用。